MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-09-0006491
Aktis Pharma India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.85 Cr
▲ 12% YoY
Net profit · FY 2025
₹35.07 Lakh
Net margin 5.1%
EBITDA · FY 2025
₹49.45 Lakh
EBITDA margin 7.2%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Aktis Pharma India Private Limited
Data last updated:
Aktis Pharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC099593. Its GSTIN is 36AANCA5937G1ZE (Telangana).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Prashanth Chikkulapally and Ram Narayana Reddy Gabbireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.85 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹35.07 Lakh (net margin 5.1%) and EBITDA of ₹49.45 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 29% over five years.
Aktis Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0006491). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aktispharma.com.
Company details
CIN U24100TG2015PTC099593
Registration Number 099593
Incorporation Date 03 July 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0006491
Key People
Prashanth Chikkulapally Director Ram Narayana Reddy Gabbireddy Director Narayana Reddy Nussam Director Recognitions & Rankings of Aktis Pharma India
Contact details
Aktis Pharma India Private Limited's registered office is in Hyderabad, Telangana. Its website is aktispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No 7 – 1 – 636/27/A Ground Floor, Model Colony Near Esi Hospital, Hyderabad, Telangana, India – 500038
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aktis Pharma India Private Limited, buy the company report.
Comprehensive company report
Aktis Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aktis Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aktis Pharma India Private Limited, buy the company report.
Financials of Aktis Pharma India Private Limited
FY 2025 filings availableAktis Pharma India Private Limited reported revenue of ₹6.85 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹6.85 Cr ▲ 12%
Net profit · FY 2025
₹35.07 Lakh margin 5.1%
EBITDA · FY 2025
₹49.45 Lakh margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 28%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 29%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 12% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aktis Pharma India Private Limited, buy the company report.
Board of directors of Aktis Pharma India Private Limited
Aktis Pharma India has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashanth Chikkulapally Also directs: Eventooz Private Limited | Director | 03 Jul 2015 | 11 Years 3 Months | Current |
| Ram Narayana Reddy Gabbireddy Also directs: Aktis Marketing LLP | Director | 03 Jul 2015 | 11 Years 3 Months | Current |
| Narayana Reddy Nussam | Director | 03 Jul 2015 | 11 Years 3 Months | Current |
| Chintharlapalli Sudhakar Reddy | Director | 03 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Aktis Pharma India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tenatra Exports Private Limited | ₹6.88 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Achyut Healthcare Limited | ₹6.86 Cr (FY 2024) | 109.0% | Ahmedabad, Gujarat, India | |||
| Aktis Pharma India Private Limitedthis company | ₹6.85 Cr (FY 2025) | ₹35.07 Lakh | 5.1% | 12.0% | Hyderabad, Telangana, India | |
| Bhairav Health and Wellness Private Limited | ₹6.83 Cr (FY 2020) | 13.0% | Panvel, Maharashtra, India | |||
| Clivia Pharma Private Limited | ₹6.83 Cr (FY 2025) | 50.0% | Palarivattom, Kerala, India | |||
| Nirkm Healthcare Private Limited | ₹6.83 Cr (FY 2025) | 0.0% | Ernakulam, Kerala, India |
To see the full peer comparison of Aktis Pharma India Private Limited, buy the company report.
Shareholding
The shareholding of Aktis Pharma India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Aktis Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aktis Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aktis Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aktis Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCA5937G1ZE | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aktis Pharma India Private Limited, buy the company report.
Recent activity
Aktis Pharma India Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Chintharlapalli Sudhakar Reddy was appointed as Director on 03 Jul 2015.
AGM
Aktis Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aktis Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Chintharlapalli Sudhakar Reddy was appointed as Director.
Appointed
Narayana Reddy Nussam was appointed as Director.
Appointed
Prashanth Chikkulapally was appointed as Director.
Appointed
Ram Narayana Reddy Gabbireddy was appointed as Director.
Incorporation
03 Jul 2015
Aktis Pharma India Private Limited was registered on 03 Jul 2015 with Roc Hyderabad & aged 11 years 4 months as per MCA records.
Frequently asked questions
Aktis Pharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 July 2015 (11+ years old) and is registered under CIN U24100TG2015PTC099593.
Aktis Pharma India has 4 current directors:
- Prashanth Chikkulapally - Director
- Ram Narayana Reddy Gabbireddy - Director
- Narayana Reddy Nussam - Director
- Chintharlapalli Sudhakar Reddy - Director
The latest financial statements of Aktis Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Aktis Pharma India is 36AANCA5937G1ZE, registered in Telangana.
The CIN (Corporate Identification Number) of Aktis Pharma India is U24100TG2015PTC099593. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aktis Pharma India was incorporated on 03 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aktis Pharma India by revenue are Tenatra Exports Private Limited, Achyut Healthcare Limited, Bhairav Health and Wellness Private Limited, Clivia Pharma Private Limited, Nirkm Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Chintharlapalli Sudhakar Reddy was appointed as Director on 03 Jul 2015. Narayana Reddy Nussam was appointed as Director on 03 Jul 2015. Prashanth Chikkulapally was appointed as Director on 03 Jul 2015. Aktis Pharma India has 4 board changes on record in total.
Yes, Aktis Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0006491).
Aktis Pharma India can be reached through the website aktispharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Aktis Pharma India is at H.No 7 – 1 – 63627A Ground Floor, Model Colony Near Esi Hospital, Hyderabad, Telangana, India – 500038.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages